Title |
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
|
---|---|
Published in |
BMC Cancer, September 2014
|
DOI | 10.1186/1471-2407-14-706 |
Pubmed ID | |
Authors |
Yoshito Hayashi, Tsutomu Nishida, Masahiko Tsujii, Shusaku Tsutsui, Katsumi Yamamoto, Fumiaki Isohashi, Makoto Yamasaki, Hiroshi Miyata, Motohiko Kato, Takuya Yamada, Shinichiro Shinzaki, Hideki Iijima, Kazuhiko Ogawa, Yuichiro Doki, Tetsuo Takehara |
Abstract |
Chemoradiotherapy (CRT) is an effective modality for stage I esophageal squamous cell carcinoma (ESCC). However, salvage treatments are often required even if complete response (CR) has been achieved. To this end, it is important to accurately diagnose lymph node or other organ metastatic recurrences. Note that lymph node enlargements (except metastatic recurrence) are often detected during the follow-up period after CRT. The purpose of this study was to elucidate the clinical characteristics of lymph node enlargement after CRT. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 21% |
Student > Ph. D. Student | 3 | 16% |
Lecturer | 1 | 5% |
Student > Bachelor | 1 | 5% |
Librarian | 1 | 5% |
Other | 4 | 21% |
Unknown | 5 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 37% |
Nursing and Health Professions | 3 | 16% |
Agricultural and Biological Sciences | 1 | 5% |
Philosophy | 1 | 5% |
Economics, Econometrics and Finance | 1 | 5% |
Other | 1 | 5% |
Unknown | 5 | 26% |